CAPSTONE INVESTMENT ADVISORS, LLC

Position in UTHR — UNITED THERAPEUTICS Corp

CIK 1426196 NEW YORK, NY

Back to UTHR Full portfolio

Position in UTHR

as of Jun 30, 2026 · filed Aug 17, 2026 Compact

Position Value

$608,475

-$27,792 QoQ

Shares Held

1,123

+4.7% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#535

of 870 holders

Holding Since

Sep 2023

10 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Common Shares in UTHR Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

CAPSTONE INVESTMENT ADVISORS, LLC holds $5,128,141 across 6 Drug Manufacturers - Specialty & Generic names. UTHR ranks #3 (11.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	35,180	$2,528,034
2	ANIP	Ani Pharmaceuticals Inc	11,150	$922,997
3	UTHR	UNITED THERAPEUTICS Corp This page	1,123	$608,475
4	HIMS	Hims & Hers Health, Inc.	13,568	$470,402
5	SUPN	Supernus Pharmaceuticals, Inc.	6,902	$321,012
6	LQDA	Liquidia Corp	3,477	$277,221

All Filings in UTHR

Export CSV

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$608,475	1,123	+4.7%	Shares	Defined	2026-08-17
2026-03-31	$636,267	1,073	-6.6%	Shares	Defined	2026-05-15
2025-12-31	$559,850	1,149	+67.7%	Shares	Defined	2026-02-17
2025-09-30	$287,158	685	-6.9%	Shares	Defined	2025-11-14
2025-03-31	$226,886	736	-9.4%	Shares	Sole	2025-05-15
2024-09-30	$290,980	812	-23.7%	Shares	Sole	2024-11-14
2024-06-30	$338,937	1,064	-79.0%	Shares	Sole	2024-08-14
2024-03-31	$1,162,842	5,062	+90.9%	Shares	Sole	2024-05-01
2023-12-31	$583,148	2,652	+41.5%	Shares	Sole	2024-02-12
2023-09-30	$423,280	1,874	—	Shares	Sole	2023-11-13
No filing history on record for this holder in this stock.